![semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)](https://static.elsevier.es/multimedia/00017310/0000011500000001/v1_202401030514/S0001731023008505/v1_202401030514/en/main.assets/gr2.jpeg)
semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)
USD22.62
USD60.62
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
![semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)](https://pbs.twimg.com/media/HNR_j1YWQAAxxhS?format=webp&name=medium)
![semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)](https://research.weill.cornell.edu/sites/default/files/news_images/oral_vs_injectable_glp-1s_0.png)
![semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)](https://d1svk58pjf7hyt.cloudfront.net/wp-content/uploads/sites/6/2024/10/ozempic-insulin-injection-pen-for-diabetics.jpg_s1024x1024wisk20c2zxETOXZNKLCiCuTxS_Vyy6FcH2b9zv3kKlhsueFMGY.jpg)
![semaglutide and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Highlights by Novo Nordisk (@novonordisk)](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202024-11-26T074836.306.jpg?VersionId=n1Ao42.CIq6Y1Vbz63e3G3em3f43w.pa)
